Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer.

Donington J, Ferguson M, Mazzone P, Handy J Jr, Schuchert M, Fernando H, Loo B Jr, Lanuti M, de Hoyos A, Detterbeck F, Pennathur A, Howington J, Landreneau R, Silvestri G; Thoracic Oncology Network of American College of Chest Physicians; Workforce on Evidence-Based Surgery of Society of Thoracic Surgeons.

Chest. 2012 Dec;142(6):1620-35. doi: 10.1378/chest.12-0790.

PMID:
23208335
[PubMed - indexed for MEDLINE]
2.

Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC.

Chest. 2013 May;143(5 Suppl):e278S-313S. doi: 10.1378/chest.12-2359.

PMID:
23649443
[PubMed - indexed for MEDLINE]
3.

Video assisted thoracoscopic surgery and lobectomy, sublobar resection, radiofrequency ablation, and stereotactic radiosurgery: advances and controversies in the management of early stage non-small cell lung cancer.

Pennathur A, Abbas G, Christie N, Landreneau R, Luketich JD.

Curr Opin Pulm Med. 2007 Jul;13(4):267-70. Review.

PMID:
17534171
[PubMed - indexed for MEDLINE]
4.

American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer.

Fernando HC, Timmerman R.

J Thorac Cardiovasc Surg. 2012 Sep;144(3):S35-8. doi: 10.1016/j.jtcvs.2012.06.003. Epub 2012 Jul 11.

PMID:
22795435
[PubMed - indexed for MEDLINE]
5.

New therapeutic approaches for early stage non-small cell lung cancer.

El-Sherif A, Luketich JD, Landreneau RJ, Fernando HC.

Surg Oncol. 2005 Jul;14(1):27-32. Epub 2005 Jan 17. Review.

PMID:
15777887
[PubMed - indexed for MEDLINE]
6.

Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Kozower BD, Larner JM, Detterbeck FC, Jones DR.

Chest. 2013 May;143(5 Suppl):e369S-99S. doi: 10.1378/chest.12-2362.

PMID:
23649447
[PubMed - indexed for MEDLINE]
8.

Management of early stage non-small cell lung cancer in high-risk patients.

Donington JS, Blasberg JD.

Thorac Surg Clin. 2012 Feb;22(1):55-65, vi. doi: 10.1016/j.thorsurg.2011.08.018. Epub 2011 Oct 24. Review.

PMID:
22108689
[PubMed - indexed for MEDLINE]
9.

Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).

Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K; American College of Chest Physicians.

Chest. 2007 Sep;132(3 Suppl):234S-242S.

PMID:
17873171
[PubMed - indexed for MEDLINE]
10.

Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).

Crabtree T, Puri V, Timmerman R, Fernando H, Bradley J, Decker PA, Paulus R, Putnum JB Jr, Dupuy DE, Meyers B.

J Thorac Cardiovasc Surg. 2013 Mar;145(3):692-9. doi: 10.1016/j.jtcvs.2012.10.038. Epub 2012 Nov 20.

PMID:
23174176
[PubMed - indexed for MEDLINE]
11.

Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy.

Forquer JA, Fakiris AJ, McGarry RC, Cheung MK, Watson C, Harkenrider M, Henderson MA, Lo SS.

Expert Rev Anticancer Ther. 2009 Oct;9(10):1443-53. doi: 10.1586/era.09.117. Review. Erratum in: Expert Rev Anticancer Ther. 2009 Dec;9(12):1876.

PMID:
19828006
[PubMed - indexed for MEDLINE]
12.

Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer.

Zemlyak A, Moore WH, Bilfinger TV.

J Am Coll Surg. 2010 Jul;211(1):68-72. doi: 10.1016/j.jamcollsurg.2010.03.020. Epub 2010 May 26.

PMID:
20610251
[PubMed - indexed for MEDLINE]
13.

Role of adjuvant radiation (external beam/brachytherapy) for stage I NSCLC.

Ketchedjian A, DiPetrillo TA, Daly B, Fernando HC.

Thorac Surg Clin. 2007 May;17(2):273-8. Review.

PMID:
17626405
[PubMed - indexed for MEDLINE]
14.

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D.

J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221. Review.

PMID:
21252716
[PubMed - indexed for MEDLINE]
15.

Approaching the high-risk patient: sublobar resection, stereotactic body radiation therapy, or radiofrequency ablation.

Fernando HC, Schuchert M, Landreneau R, Daly BT.

Ann Thorac Surg. 2010 Jun;89(6):S2123-7. doi: 10.1016/j.athoracsur.2010.02.101. Review.

PMID:
20493995
[PubMed - indexed for MEDLINE]
16.

Sublobar resection for early-stage lung cancer.

Schuchert MJ, Abbas G, Pennathur A, Nason KS, Wilson DO, Luketich JD, Landreneau RJ.

Semin Thorac Cardiovasc Surg. 2010 Spring;22(1):22-31. doi: 10.1053/j.semtcvs.2010.04.004. Review.

PMID:
20813313
[PubMed - indexed for MEDLINE]
17.

Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.

Voynov G, Heron DE, Lin CJ, Burton S, Chen A, Quinn A, Santos R, Colonias A, Landreneau RJ.

Brachytherapy. 2005;4(4):278-85.

PMID:
16344258
[PubMed - indexed for MEDLINE]
18.

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.

Carr SR, Schuchert MJ, Pennathur A, Wilson DO, Siegfried JM, Luketich JD, Landreneau RJ.

J Thorac Cardiovasc Surg. 2012 Feb;143(2):390-7. doi: 10.1016/j.jtcvs.2011.10.023. Epub 2011 Dec 9.

PMID:
22169444
[PubMed - indexed for MEDLINE]
19.

Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.

Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris HB.

Ann Thorac Surg. 2005 Jul;80(1):268-74; discussion 274-5.

PMID:
15975380
[PubMed - indexed for MEDLINE]
20.

Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.

El-Sherif A, Gooding WE, Santos R, Pettiford B, Ferson PF, Fernando HC, Urda SJ, Luketich JD, Landreneau RJ.

Ann Thorac Surg. 2006 Aug;82(2):408-15; discussion 415-6.

PMID:
16863738
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk